Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q96042461 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235942.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q96042461 | ||
| 024 | ‡a 0000-0003-3112-5335 ‡2 orcid | ||
| 024 | ‡a 26431250200 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q96042461 | ||
| 100 | 0 | ‡a David Aparicio ‡c researcher (ORCID 0000-0003-3112-5335) ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a David Aparicio ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Crystal structure of (2S,4R)-ethyl 4-nitro-methyl-1-[(S)-1-phenyl-eth-yl]-6-sulfanyl-idene-piperidine-2-carboxyl-ate | ||
| 909 | ‡a (scopus) 26431250200 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000331125335 ‡9 1 | ||
| 919 | ‡a crystalstructureof2s4rethyl4nitromethyl16sulfanylidenepiperidine2carboxylate ‡A Crystal structure of (2S,4R)-ethyl 4-nitro-methyl-1-[(S)-1-phenyl-eth-yl]-6-sulfanyl-idene-piperidine-2-carboxyl-ate ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 BNE|XX949814 | ||
| 996 | ‡2 BNF|17882154 | ||
| 996 | ‡2 BNC|981058609576406706 | ||
| 996 | ‡2 PTBNP|1772219 | ||
| 996 | ‡2 BNE|XX1715392 | ||
| 996 | ‡2 LC|no2010162555 | ||
| 996 | ‡2 SUDOC|254187587 | ||
| 996 | ‡2 BNE|XX5151245 | ||
| 996 | ‡2 ISNI|0000000103853488 | ||
| 996 | ‡2 DNB|1153161079 | ||
| 996 | ‡2 BNE|XX1633315 | ||
| 996 | ‡2 ISNI|0000000504112410 | ||
| 996 | ‡2 LC|n 2018025503 | ||
| 996 | ‡2 ISNI|0000000358773690 | ||
| 996 | ‡2 ISNI|0000000060544350 | ||
| 996 | ‡2 BNE|XX995699 | ||
| 996 | ‡2 LC|n 2023054857 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
